chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient reported numbness of right side from jaw to fingertips within 15minutes of receiving vacine
It started on 12/21/2020 from dose 1. I noticed that my lips were swollen and irritated, peeling , burning , irritation goes half way to my nose .. The swelling and irritation never went away . I  was still  irritated and swollen  as I received the second dose.. I am still having issues.
Patient stated that about 8 days after she received her 1st dose of Pfizer vaccine, her menstrual cycle started. Patient has been going through menopause since the summer of 2019. Patient has not went and seen doctor for Adverse Events yet.
1/9/2031:  at time of shot extreme burning in left arm and into left shoulder blade. 15-30 minutes after vaccine: high pulse at 98 bpm, throat tightened, shake hands (lasted 1 hour)(had to take allergy pill for throat tightening) High anxiety the rest of the day. Sharp pain in left shoulder blade into neck, extreme fatigue.  1/10/2021: high fatigue, sharp shoulder blade pain and stiffness in neck. Right kidney/back pain, headache, fuzzy thinking, feeling blah and out of it  1/11/2021: arm, shoulder blade and neck pain, heart racing in the  am.  1/12/2021: shoulder blade and neck pain. Afternoon nausea and feeling like I could throw up, clamy sweaty hands
Pt left office 15 min after called with complaints of vaginal itching, welts all over body. Rec. Benadryl, face lips and ears start swelling. Pt goes to ER. Given dexamethasone tablet, swelling going down.
Patient said she had a red, sore arm and didn't feel well. She put ice on it and took fever reducers. Was sore for 10 days.
Rash developed 2 weeks after vaccine, raised, red, blister-like, worsening and spreading 3rd week after week vaccine. Not painful or itchy. Advised to contact Dr.
Got my 1st dose on December 20 2020 no side effects just a sore arm.  Got my 2nd dose on January 8 2021 just a sore arm. A week later on January 15 I started to itch from head to toe all over my body. On January 25 woke up with hives/rash that is on and off all over my body. I am still itchy and still occasionally have the rash. Have been to my pcp and a dermatologist and as of 1/9/21 they do not have a reason to how or why this happened.  Nothing in my daily life has changed soaps, detergent, food, drink, work gloves.
I experienced a lot of joint muscle pain to the extent I couldn't walk and had muscle spasms. I had gone to the doctor, had MRI, X-rays, referred to Physical therapy for moderate relief and epidural. I fell out on November 15, 2021 at the store and went to the hospital. They found out I had blood clots in my lungs prescribed me Eliquis. I stopped taking Eliquis February 16, 2022.
around 1:00 a.m. I awoke with stomach pain and had diarrhea. I continued to have stomach pains and had diarrhea again around 2-3:00a.m.  Stomach pain continued. At approximately 4:00 a.m. I vomited.  I continued to have stomach pain, back pain, vomiting and diarrhea.  I vomited every hour from 4:00 a.m. to 10:00 a.m. whether or not I consumed any liquids. At approximately 10:45a.m. I took an anti-nausea medication proscribed by a healthcare provider and the vomiting ceased.  I continued to have stomach and back pains for the remainder of the day.  I felt better the following day, but still had back pain/soreness.
Complained of next day after received vaccine developed rash to chest, legs, arms, eyes swollen and lots of itching. Referred to clinic for evaluation with treatment per MD.  Follow up telephone call with client 06/10/04.  States was seen at clinic per MD at ER due to continue with rash about 12:30 given Benadryl injection and Benadryl pills. Told rash...breakout due to unknown etiology should consider referral to allergist.  06/10/04: Medical records request form faxed to clinic where pt treated initially on 06/01/04.  06/14/04: Follow up clinic takes 3-5 business days to send MR out.
Patient administered vaccine after the manufacture's date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) in a 63-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine after the manufacture's date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The vial did not undergo any temperature excursions. Date the vial initially stored in the refrigerator was unknown.  Treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up received reporter's address updated.
Redness; soreness; headache; sore/swollen lymph nodes under left arm pit; left side of left breast was sore and was purple and looked bruised.
Patient called and said she was still having discomfort in the arm, 2 weeks after her flu shot. I told her I thought that was a long time and suggested she call her MD.
I had a slight sore throat on night of getting vaccine.  On the day after, I had chills, body aches, chest tightness and pain, shortness of breath and  Wheezing.
Rash over trunk and itching for approx. 20 minutes, post vax.
Two errythemic tender warmth areas on exam today. Does appear to be infectious, also consider allergic. Will treat with keflex, also gave cetirizine. F/u with any worsening symptoms or if not improving in next 2-3 days.
This spontaneous report as received from a nurse refers to a female patient of unknown age. On 13-JAN-2014 the patient was vaccinated with GARDASIL, .5 ml, intramuscularly. On 13-JAN-2014, the patient's blood test was positive for pregnancy. The patient experienced no adverse effect. The outcome of blood test was positive for pregnancy and no adverse effect is unknown. Additional information has been requested.
started having hives around the injection site; there is redness and pain at the injection site; Swelling at the injection site; Redness at the injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 05-SEP-2023, the patient received the 1st dose of Shingrix (left arm). On 05-SEP-2023, less than a day after receiving Shingrix, the patient experienced injection site hives (Verbatim: started having hives around the injection site). In SEP-2023, the patient experienced injection site pain (Verbatim: there is redness and pain at the injection site), injection site swelling (Verbatim: Swelling at the injection site) and injection site erythema (Verbatim: Redness at the injection site).  On 08-SEP-2023, the outcome of the injection site hives was resolved (duration 3 days). The outcome of the injection site pain and injection site swelling were unknown and the outcome of the injection site erythema was not resolved.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema and injection site hives to be related to Shingrix.     It was unknown if the company considered the injection site pain, injection site swelling, injection site erythema and injection site hives to be related to Shingrix.   Additional Information: GSK Receipt Date: 08-SEP-2023 The patient self-reported this case. On the vaccination day, the patient started having hives around the injection site, by Wednesday the hives were really bad.  The hives were gone today (on the reporting day) and there was redness and pain at the injection site. The reporter did not consent to follow-up.
Meniere's disease, which had been under control for several years (perhaps a once monthly-or less- episode),  impacted daily life to where I could no longer work full time for three months.  One week, had severe vertigo 5 out of 7 days, the shortest episode lasting 4 hour, many lasting up to 10 or 12 hours.  The episodes decreased gradually over time,  but required increased medication and many doctor visits  and PT to calm vestibular system.  PT-3 x a week for 2 months Medications now taking: Imitrex (perhaps migraine induced) as needed Triamerene 37.5 mg daily Nortriptyline 10mg  daily Oxazepam 10mg as needed Episodes have significantly decreased, and short episodes of lack of balance have decreased as well.  Still not 100% to where I was at the beginning of winter, but getting there.   I have opted for Johnson's for booster shot and hopefully a different type of vaccine (not mRNA) will not have the same side effects.  Reported to Dr, but he said that there was no research at the time indicating increased episodes of vertigo related to vaccine.
The second dose has given me terrible headaches; Pain in the left arm; Pain in the left armpit; I am unable to fully use my left arm. The mobility of it is highly restricted due to the pain in the bicep/armpit.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732) via an unspecified route of administration in the left arm on 20Apr2021 at 14:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, osteoarthritis, hypertension, pre-diabetes and psoriasis. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included bisoprolol (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and metformin (MANUFACTURER UNKNOWN) all for an unknown indications since an unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6202) via an unspecified route of administration in the left arm on 31Mar2021 at 12:15 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. On 20Apr2021 at 21:00, the second dose had given the patient terrible headaches, pain in his left arm / left armpit that was of a similar feeling to a torn muscle (specifically centered around the vaccination site) and the patient was unable to fully use his left arm. The mobility of it was highly restricted due to the pain in the bicep / armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events terrible headaches, pain in the left arm / left armpit and mobility was highly restricted was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
took the first maderna shot three months ago/took the first shot in February; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (took the first maderna shot three months ago/took the first shot in February) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (took the first maderna shot three months ago/took the first shot in February). At the time of the report, PRODUCT DOSE OMISSION ISSUE (took the first maderna shot three months ago/took the first shot in February) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .
Information has been received from a registered nurse concerning a 12 month old female patient with no drug reactions or allergies, who on 20-MAY-1997 was vaccinated with a first dose of RECOMBIVAX HB (Lot # not reported). On 12-JUN-1997 the patient received the second dose of RECOMBIVAX HB (Lot # not reported) and on 14-MAY-1998 received the third dose. The nurse reported that the patient's hepatitis B titer was negative after receiving three doses of RECOMBIVAX HB or other hepatitis B vaccines when the patient was an infant. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Pain at injection site; Fever; Body aches; Headache; Weakness/lethargy; Weakness/lethargy; This is a spontaneous report received from a contactable consumer (patient). This 43-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ER8729) on 11Apr2021 14:15 in left arm at single dose for COVID-19 immunization. Medical history included high cholesterol, high blood pressure. No allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not provided. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: ER8727) in Mar2021 14:30 in left arm at single dose for COVID-19 immunization and after the first dose, experienced strong soreness at injection site. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. After second dose, starting 12 hours after injection, on 12Apr2021 15:00, patient experienced pain at injection site, fever, body aches, headache, weakness/lethargy. Symptoms fully resolved 48 hours after injection. No treatment received for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovered on 13Apr2021.  No follow-up attempts are needed. No further information is expected.
Information has been received from a nurse practitioner concerning a 17 year old female who on 14-AUG-2007 was vaccinated with Gardasil. On 14-AUG-2007, the spring on the syringe did not release, so she pushed harder on the plungers before withdrawing the syringes from the patient's arm. The patient complained that the injection hurt. Unspecified medical attention was sought. The outcome was not reported. Additional information has been requested.
her husband only experienced a sore arm; This is a follow up spontaneous report from a Pfizer-sponsored program. A contactable consumer (Patient's wife) reported for a male patient. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), dose 1 via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that her husband only experienced a sore arm on an unspecified date. Outcome of the event was unknown  Information about lot/batch number has been requested. Follow-up attempts completed. No further information expected.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
pt has had fever off & on over the course of two weeks from 48hr p/vax;pt also devel a reddish rash on either side of mouth that lasted 3 or 4 days;pt did not exp fever or rash until p/shots;
1 of 2 pts devel dollar-sized area of erythema, edema, warmth & pain @ inject site; tx w/DPH & warm compresses; resolved w/in 48 hrs;
Patient  was admitted on 1/5/2022 for chief complaint of behavioral change and low blood pressure. Patient has past medical history of developmental/cognitive delay and is non-verbal at baseline. Patient resides at AFC home and was noted to have behavioral changes. He was found to be positive for Covid-19 1 day prior to presentation. He was hypotensive on presentation and required vasopressor support and ICU admission. He was noted to be hypoxic and was placed on supplemental O2 and started on dexamethasone and remdesivir for Covid-19. His blood pressures improved and he was transferred out of ICU. His respiratory status improved and he was weaned to room air. Lisinopril was stopped during this admission due to low-normal BP.
About 6 hours after injection, injection site pain worsened. This continued to worsen until about 48H post-injection. About 30 hours from injection, experienced aches and feverish feeling without elevated temperature. Aches primarily in joints of hands, feet, knees, back pain, neck stiffness.
Tripped over something in house; Extreme pain in back of arm in the muscle; This spontaneous case was reported by a consumer and describes the occurrence of FALL (Tripped over something in house) and MYALGIA (Extreme pain in back of arm in the muscle) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced MYALGIA (Extreme pain in back of arm in the muscle). On an unknown date, the patient experienced FALL (Tripped over something in house). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Pain, at an unspecified dose and frequency. At the time of the report, FALL (Tripped over something in house) outcome was unknown and MYALGIA (Extreme pain in back of arm in the muscle) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
w/in a wk of shots pt started to make a strange movement w/upper body, head & arms; pt would cry during this & would go to sleep shortly p/; began to slowly regress in all of motor skills & stopped smiling or responding to anyone;
Face was crooked like she had a stroke; Could not move arms and legs; A spontaneous report was received from a consumer concerning a 67 Years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced face was crooked like a stroke/cerebrovascular accident, could not move arms and legs/paraplegia.  The patient medical history included stage IV cancer and multiple sclerosis. No relevant concomitant medications were reported.  On 09 Mar 2021, prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273(batch no: 011a21a) intramuscularly for prophylaxis of COVID-19 infection.  On 09 Mar 2021, approximately an hour after receiving the vaccine, the patient's face was crooked like she had a stroke. She also could not move her arms and legs. The reporter called 911 and the patient went back to normal 45 minutes after ambulance had come.   Laboratory details are not provided. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not applicable, as the patient received both their doses.   The outcome of the events, face was crooked like a stroke, could not move arms and could not move legs were considered resolved on 09 Mar 2021; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
One day after immunization eryth + warmth at sight left MMR thigh. Keflex started-failed. Seen 2 days after immunization and admitted for left thigh cellulitis + I ALSX. Responded well to IV Clindamycin. Note 2nd cellulitis in three weeks. Different immunization same nurse at office.
Patient has inadvertently received a pediatric dose instead of an adult dose of the Pfizer COVID 19 vaccine on 1/31 by me. I was scheduled as a clinical lead and spent most part of the day overseeing patients that have completed vaccination and were in the waiting area. Facility introduced a new vaccination log protocol, and I wanted to vaccinate patients in order to be proficient at the new system. Around 1545 vaccinators packed up with the clinical site RN manager encouragement to make sure "no one gets overtime". The vaccine rotating member took all the vaccine syringes I had in the vaccine box, except for the two orange capped ones. It was 1558 when two family members and the guardian arrived at the vaccination station. Patient's brother (10 years of age) was the first to get the vaccine. His weight wasn't taken, so I had to walk to the scale with him, measure and document his weight first. The guardian seemed in a rush and offered to check Patient's weight for me, so they can leave sooner. Additionally, they had an argument amongst them regarding the "do Not Disturb" feature that Patient activated on his guardian's phone. Lastly, Patient looked below normal weight range for his age, so it didn't raise al alarm having a pediatric dose in the vaccination box at my station. The vaccine was administered, no side effects were reported.
Dizziness, headache, nausea/vomiting, diarrhea, inflammation at injection site.
Sedation, Myalgia, Fever RespDepression, NauseaVomiting, CHILLS AND PAIN, SWOLLEN KNOT AT INJ SITE Narrative:
Mother awakened in early morning and noticed that patient was not breathing or moving. Resuscitation attempted by father and by EMS and hospital personnel. By report, first recorded temperature during resuscitation was 102 F. Pulse was never reported to have been attained.  4/1/08 Autopsy report states COD as sudden unexplained infant death & manner of death not determined.  Report states patient had recent URI.  Found unresponsive on soft pillow on couch w/parent.
urticaria upper back, chest & extremities; generalized erythema w/pruritus, lt arm & back, extended to trunk & extremities; facial edema (periorbital); mild/mod bronchospasm
Localized swelling and redness, extending from site of injection up to neck/scalp. Increased in size until 48 hours after injection, then began fading . Today with slight redness around injection site as well as on neck.
Swollen painful lumps in breast,  swollen lymph nodes in neck,  hourse cough, wheezing